Orion Clinical Research

Orion Clinical was a specialist contract research organization (CRO) that provided full-service clinical development solutions to the pharmaceutical, biotechnology, and medical device industries. Headquartered in the United Kingdom, the company focused on managing complex Phase I-IV clinical trials with a particular emphasis on oncology, rare diseases, and infectious diseases. Orion Clinical established a strong operational presence across Europe, North America, and emerging markets like India and South Africa. In 2016, the company was acquired by Pharm-Olam International to bolster its therapeutic expertise and global footprint. Following the acquisition of Pharm-Olam by ICON plc in 2022, Orion's legacy operations have been fully integrated into ICON's global clinical research infrastructure.